Zydus Wellness Ltd is Rated Sell by MarketsMOJO

Jan 20 2026 10:10 AM IST
share
Share Via
Zydus Wellness Ltd is rated Sell by MarketsMojo, with this rating last updated on 08 Jan 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 January 2026, providing investors with the latest insights into the company’s performance and outlook.
Zydus Wellness Ltd is Rated Sell by MarketsMOJO



Current Rating Overview


MarketsMOJO’s current rating of Sell for Zydus Wellness Ltd is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. This rating suggests that investors should exercise caution with this stock, as the company’s fundamentals and market indicators point to challenges ahead. The Mojo Score currently stands at 47.0, down from 54.0 at the previous rating update, reflecting a deterioration in the overall assessment.



Quality Assessment


As of 20 January 2026, Zydus Wellness’s quality grade is considered average. The company has demonstrated moderate growth in net sales, with a compound annual growth rate (CAGR) of 11.17% over the past five years. However, operating profit growth has been sluggish, registering only 4.33% annually during the same period. This disparity indicates that while top-line expansion is steady, operational efficiency and profitability have not kept pace, which weighs on the company’s quality score.



Valuation Perspective


The valuation grade for Zydus Wellness is currently fair. The stock’s market capitalisation remains in the small-cap segment, which often entails higher volatility and risk. Despite this, the valuation metrics do not suggest extreme overvaluation or undervaluation relative to peers in the FMCG sector. Investors should note that fair valuation does not imply a bargain but rather a balanced price level given the company’s financial health and growth prospects.



Financial Trend Analysis


The financial trend for Zydus Wellness is negative as of today. Recent quarterly results reveal significant deterioration in profitability metrics. The Profit Before Tax excluding Other Income (PBT less OI) for the latest quarter stands at a loss of ₹17.80 crores, marking a steep decline of 121.3% compared to the average of the previous four quarters. Similarly, the Profit After Tax (PAT) has fallen by 123.1% to a loss of ₹18.60 crores. Earnings per share (EPS) have also hit a low of ₹-1.66, signalling mounting losses. These figures highlight operational challenges and margin pressures that have adversely affected the company’s financial trajectory.



Technical Indicators


From a technical standpoint, the stock exhibits a mildly bullish grade. Despite recent price declines, including a 1-day drop of 1.33% and a 1-week fall of 4.68%, the stock has delivered a positive 1-year return of 11.28% as of 20 January 2026. However, shorter-term trends show weakness, with a 3-month decline of 10.64% and a year-to-date drop of 8.08%. This mixed technical picture suggests some underlying support but also notable volatility and uncertainty in the near term.



Stock Performance Summary


Currently, Zydus Wellness’s stock performance reflects a challenging environment. The 6-month return is nearly flat at -0.04%, while the 1-month return is negative at -1.69%. These figures, combined with the negative financial trend and average quality, underpin the cautious stance reflected in the Sell rating. Investors should be mindful of these dynamics when considering exposure to this stock.



Implications for Investors


The Sell rating indicates that MarketsMOJO’s analysis does not favour holding or buying Zydus Wellness shares at this time. The combination of average quality, fair valuation, negative financial trends, and mixed technical signals suggests that the stock may face headwinds in the near to medium term. Investors seeking stability and growth within the FMCG sector might consider alternative opportunities with stronger fundamentals and more positive outlooks.



Sector and Market Context


Operating within the FMCG sector, Zydus Wellness faces intense competition and evolving consumer preferences. The company’s small-cap status adds an additional layer of risk, as smaller firms often have less financial flexibility and market influence. Compared to broader market indices and sector benchmarks, the stock’s recent underperformance and financial challenges highlight the need for careful scrutiny before investment.




Fresh entry alert! This Small Cap from Electronics & Appliances sector is already turning heads in our Top 1% club. Get ahead of the market now!



  • - New Top 1% entry

  • - Market attention building

  • - Early positioning opportunity


Get Ahead - View Details →




Summary and Outlook


In summary, Zydus Wellness Ltd’s current Sell rating by MarketsMOJO reflects a cautious view grounded in the company’s recent financial performance and market behaviour. While the stock has shown some resilience over the past year, the latest quarterly losses and subdued growth metrics raise concerns about near-term profitability and operational efficiency. The fair valuation and mildly bullish technical indicators offer limited comfort but do not offset the negative financial trend and average quality assessment.



For investors, this rating serves as a signal to reassess exposure to Zydus Wellness and consider the risks involved. Monitoring upcoming quarterly results and sector developments will be crucial to gauge any potential turnaround or further deterioration. Until then, the Sell rating advises prudence and careful portfolio management.



Key Financial Metrics as of 20 January 2026


• Net Sales CAGR (5 years): 11.17%

• Operating Profit CAGR (5 years): 4.33%

• Latest Quarterly PBT less Other Income: ₹-17.80 crores

• Latest Quarterly PAT: ₹-18.60 crores

• Latest Quarterly EPS: ₹-1.66

• 1-Year Stock Return: +11.28%

• Year-to-Date Return: -8.08%



These figures provide a snapshot of the company’s current financial health and market performance, underpinning the rationale behind the Sell rating.



Investor Takeaway


Investors should interpret the Sell rating as a recommendation to exercise caution and possibly reduce holdings in Zydus Wellness Ltd until clearer signs of financial recovery and operational improvement emerge. The current data suggests that the company faces significant challenges that may impact shareholder value in the near term.



Continued monitoring of quarterly earnings, cash flow trends, and sector dynamics will be essential for making informed decisions regarding this stock.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News